Product
Budesonide + Albuterol Sulfate MDI 80/180 μg
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A 12-week, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT008 and PT007 Administered QID in Adults and Children 4 Years of Age or Older With AsthmaStatus: Completed, Estimated PCD: 2021-07-20